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The CCAAT/enhancer binding protein (CEBP) family of transcription factors includes five genes. In the ovary, both Cebpa and
Cebpb are essential for granulosa cell function. In this study we have explored the role of the Cebpd gene in ovarian
physiology by expression and functional studies. Here we report that Cebpd (C/EBPd) is expressed in the mouse ovary in a
highly restricted temporal and spatial pattern. In response to luteinizing hormone (LH/hCG), CEBPD expression is transiently
induced in interstitial cells and in theca cells of follicles from the primary to pre-ovulatory stage, and overlaps in part with
expression of the alpha-smooth muscle actin protein. Efficient down-regulation of CEBPD was dependent on a functional
Cebpb gene. Proliferating human theca cells in culture also express Cebpd. Cells from patients with polycystic ovarian
syndrome (PCOS) exhibited higher Cebpd expression levels. However, deletion of Cebpd in mice had no overt effect on ovarian
physiology and reproductive function. Very little is known at present about the molecular mechanisms underlying theca/
interstitial cell functions. The expression pattern of CEBPD reported here identifies a novel functional unit of mouse theca cells
of primary through tertiary follicles responding to LH/hCG together with a subset of interstitial cells. This acute stimulation of
CEBPD expression may be exploited to further characterize the hormonal regulation and function of theca and interstitial cells.
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INTRODUCTION
The ovary is a complex organ undergoing regular phases of re-
organization in response to a variety of intrinsic and extrinsic
factors. The main functional unit, the follicle is comprised of a
central oocyte, mural and cumulus granulosa cell layers, and an
outer layer of theca cells. Ovarian follicles reside within the
interstitial stroma, which also gives rise to the specialized follicular
cell types. The ovulatory surge of luteinizing hormone (LH),
produced by the pituitary, triggers a series of dramatic
morphological and physiological changes in the pre-ovulatory
follicle, culminating in ovulation and subsequent differentiation of
the follicular granulosa and theca cells into the luteal cells. While
the LH receptor signals primarily through the cAMP/PKA
pathway to influence gene expression [1] it also impacts signaling
pathways involving Janus and phosphoinositol kinases, chloride
currents, and calcium [2–5]. Transcription factors known to act
downstream of LH receptor activation include STAT1 and
STAT5 [2], GATA4 [6], EGR1 [7], and the CCAAT/enhancer
binding protein proteins CEBPA and CEBPB [8].
The CEBP family of transcription factors is comprised of five
proteins with a highly homologous carboxyterminal leucine-
zipper/basic region domain required for dimerization and DNA
binding. Each CEBP protein has unique properties regulating cell
type-specific growth and differentiation. For example, within the
hematopoietic system CEBPA is required for development of
granulocytes, while lack of CEBPB affects differentiation of the B-
cell lineage and monocytes. During adipocyte differentiation,
CEBPB, -D, and A are expressed consecutively [9]. In the
mammary gland, CEBPB promotes proliferation and differentia-
tion [10], while CEBPD participates in the initiation of cell death
[11]. In the ovary, both CEBPA and CEBPB are expressed in
follicular granulosa cells, dynamically regulated by gonadotropins,
and essential for follicular development, efficient ovulation and
luteal differentiation. In particular, CEBPB is a downstream
effector of the LH signaling pathway in granulosa cells [8]. The
absence of significant levels of CEBPA and CEBPB in theca cells
combined with the importance of these factors in mediating LH-
triggered events in granulosa cells suggested the possibility that
another member of the family may substitute for their function in
theca cells. Therefore, we investigated the expression and function
of CEBPD in the ovary.
Cebpd (C/EBPdelta, CELF, CRP3, NFIL-6beta) was first
characterized as an acute phase inflammatory response gene.
Expression of Cebpd is typically low to undetectable in most cell
types and tissues, but is rapidly induced by a variety of
extracellular stimuli, (e.g. growth hormone, insulin, IFNgamma,
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In vitro and in vivo studies have implicated CEBPD in proliferation
of osteoblasts [13,14], differentiation of lung epithelial cells [15–
17], and growth arrest of mouse mammary epithelial cells [18].
While Cebpd-deficient mice display no overt phenotype, are fertile
and achieve normal life spans, more detailed characterization
revealed that the null mutation led to improved performance in
the contextual fear conditioning test of long term memory [19],
increased mammary ductal branching [20] and delayed mammary
gland involution [11]. Furthermore, Cebpd-deficiency exacerbates
the differentiation defect of Cebpb-deficient adipocytes [21], and
causes genomic instability in fibroblasts [22]. Thus, CEBPD
appears to have highly diverse functions depending on cell type
and specific physiological stimuli. Furthermore, because its
expression is mostly activated by transient signals, the role of
CEBPD in vivo may be modulatory and only uncovered when cells
are investigated in response to specific stimuli. In this study we
have addressed whether CEBPD plays a role in ovarian physiology
through expression analyses and a thorough reproductive
characterization of Cebpd-deficient mice.
RESULTS
Dynamic regulation of Cebpd mRNA expression in
the mouse ovary
To address the role of CEBPD in the mouse ovary we first assessed
its expression pattern in response to LH administration. We used
an ovulation protocol in which mice were treated with pregnant
mare serum gonadotropin (PMSG) to stimulate the coordinated
development of multiple pre-ovulatory follicles, followed two days
later by human chorionic gonadotropin (hCG) to mimic the
ovulatory surge of LH. Northern blot analysis of whole ovary RNA
revealed a highly restricted temporal expression pattern for Cebpd
(Fig. 1). Expression of Cebpd mRNA was minimal prior to hCG
treatment, but was highly induced 2–3 hours following hCG,
before returning to pre-hCG levels by 6 hours where it remained
through 8 hours. Similar data were obtained by Western analysis
of whole ovary protein extracts (data not shown). Expression of
prostaglandin-endoperoxide synthase 2 (Ptgs2, a.k.a. Cox-2, Pghs
2), a gene known to be induced by LH in granulosa cells [23], was
evaluated as a positive control (Fig. 1). As expected, ovarian Ptgs2
expression increased following hCG treatment and then declined
rapidly. In whole ovary extracts, Cebpd and Ptgs2 mRNA
expression were regulated temporally in a similar pattern (Fig. 1).
Similar expression data were obtained from 3 week old prepu-
bertal and 5 week old postpubertal mice. Thus, we have used 5–
6 week old mice for all other expression analyses in this study.
Analysis of Cebpd expression in Cebpb null mice
Since we previously identified an essential role of Cebpb in the LH
responsiveness of granulosa cells [24], we assessed Cebpd-
expression also in Cebpb-deficient mice (Fig. 2). Cebpd mRNA
expression was induced normally by hCG in Cebpb null mice.
Expression levels at 0 h and 3 h after hCG treatment were
statistically similar in WT and KO ovaries. However, Cebpd
mRNA levels remained high in Cebpb knockout mice through five
hours of hCG treatment, in contrast to the rapid loss seen in the
controls (Fig. 2). By 8 hours following hCG, Cebpb-deficient and
control ovaries expressed similar levels of Cebpd mRNA (data not
shown). This pattern of normal induction by hCG but delayed
down-regulation is similar to the defective down-regulation of
Ptgs2 and aromatase mRNA expression in granulosa cells of Cebpb-
deficient mice [24].
Localization of Cebpd expression in theca/
interstitial cells
To determine which ovarian cell type(s) Cebpd was expressed in we
employed in situ hybridization and immunohistochemistry. Figure 3
confirms the relative lack of Cebpd expression prior to the LH
surge, and the dramatic induction of Cebpd mRNA levels following
hCG administration. This expression was localized in the theca
cell layer of follicles of varying sizes as well as in the stromal
compartment. No evidence of granulosa cell expression was
observed in any preparation. To better characterize Cebpd
expression within the stroma, immunohistochemistry was per-
formed. The anti-CEBPD rabbit polyclonal antibody detected
nuclear CEBPD protein expression in theca and interstitial cells
specifically in wild-type ovarian tissue but not in Cebpd knockout
control tissue (Fig. 4A). As seen with Cebpd mRNA, maximal
protein levels were observed 3 h after hCG treatment. However,
7 h following hCG-adminstration to mice CEBPD protein was still
detected in interstitial cells, but less so in theca cells (Fig. 4A).
Figure 1. Cebpd mRNA expression is induced by hCG in mouse
ovaries. Northern blot analysis of whole ovary total RNA isolated from 5
week-old (Exp.1) or 3 week-old (Exp.2) mice treated for 2 days with
PMSG followed by the LH analog hCG for the indicated times (n.t.=no
treatment). Ptgs2 was used as a positive control for the hCG response.
Cyclophilin (Ppi) was used as loading control.
doi:10.1371/journal.pone.0001334.g001
Figure 2. Down-regulation of Cebpd mRNA requires Cebpb.
Phosphorimage quantitation of Northern blot analyses of whole ovary
total RNA from 5 week-old Cebpb null mice (KO) or litter mate controls
(WT) treated for 2 days with PMSG followed by hCG for the indicated
times. Expression levels of Cebpd were normalized to cyclophilin (Ppi)
expression and are shown in arbitrary units (a.u.; mean6SEM; n=3–4
mice per data point). **P=0.01 by two-way ANOVA with follow-up
comparisons among groups in the form of t-tests at each time point.
doi:10.1371/journal.pone.0001334.g002
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were not evident by analysis of whole ovary mRNA (Fig. 1) or
protein extracts (data not shown). Most of the CEBPD-staining
interstitial cells exhibit small, elongated nuclei. Theca externa cells
express alpha smooth muscle actin (ACTA2) [25], and CEBPD is
also expressed in vascular smooth muscle cells [26]. Thus, we
sought to determine if CEBPD characterizes ACTA2 expressing
interstitial cells. Analysis of parallel sections revealed that ACTA2
and CEBPD stain the same layers in primary to antral follicles
(Fig. 4B). Similarly, some stromal areas that stain positive for
ACTA2 also contain CEBPD-expressing cells (Fig. 4C).
Analysis of Cebpd null mutant mice
When Cebpd null mutant mice had first been generated [19],
females and males were found to be fertile. Here we conducted a
more detailed analysis to potentially uncover effects of Cebpd
deficiency on ovarian physiology that may not be evident in assays
of fertility. Comparison of Cebpd and control mice reproductive
parameters are shown in Figure 5. No differences were observed
between Cebpd knockout and control mice with respect to the size
of their first litters (Fig. 5A). Regulation of the estrous cycle was
assessed indirectly by mating the females to sterile males and
recording mating activity. Both genotypes mated on average every
Figure 3. Cebpd mRNA expression is localized to theca and interstitial cells. Dark-field photomicrographs of in situ hybridization analyses using
Cebpd-specific sense and antisense RNA probes on sections from ovaries of 6 week-old mice treated for 2 days with PMSG followed by hCG for the
indicated times. Outlined regions in the center panels are shown at higher magnification on the right.
doi:10.1371/journal.pone.0001334.g003
Figure 4. CEBPD protein expression in mouse ovaries. (A) Immunohistochemistry for CEBPD in ovaries from wild-type (WT) or Cebpd null mutant
(KO) mice at the indicated time points following hCG treatment. (B, C) Immunohistochemistry for CEBPD and alpha smooth muscle actin (ACTA2) in
wild-type ovaries harvested 3 h after hCG treatment. Solid arrows indicate theca layers (B), open arrows indicate stromal areas (C) expressing both
CEBPD and ACTA2.
doi:10.1371/journal.pone.0001334.g004
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pseudopregnancy response to mating, which is reliant on luteal
progesterone production (Fig. 5B). Levels of progesterone were
assessed as a measure of follicular differentiation following
ovulation. Cebpd null mice and controls produced similar levels
of progesterone on day 5 of gestation and day 5 of pseudopreg-
nancy (Fig. 5C). Lastly, examination of the ovarian histology of
mice from age 70 to 400 days did not reveal abnormalities when
compared to wild-type littermates (data not shown). Taken
together, these data demonstrate that the Cebpd null mutation
does not overtly affect reproductive function in female mice.
Since a physiological response may proceed normally despite
the altered regulation of certain genes, we also analyzed the
expression of several marker genes 4 hours after hCG treatment in
knockout and wild-type ovaries (Fig. 6). No differences were
observed for the mRNA levels of several steroidogenic marker
genes, steroidogenic acute regulatory protein (Star), cytochrome
P450scc (Cyp11a1), 17-a hydroxylase (Cyp17a1), and 3b-hydroxy-
steroid dehydrogenase (Hsd3b), as well as the theca-specific tissue-
type plasminogen activator (Plat) gene [27]. Furthermore, Ptgs2,a
gene primarily expressed in granulosa cells [27], was induced to
similar levels in Cebpd knockout and control mice (Fig. 6). These
data further confirm normal ovarian function in the absence of
CEBPD.
Expression of CEBPD in cultured human theca cells
Analysis of cultured proliferating theca cells obtained from patients
with polycystic ovarian syndrome (PCOS, n=4) showed approx-
imately 3-fold higher levels of Cebpd mRNA than theca cells
isolated from women not afflicted with this syndrome (Fig. 7).
These data confirm that Cebpd expression in theca cells is not a
species-specific phenomenon as it occurs in mouse and human.
Previous microarray experiments utilizing the same RNA
preparations used in our experiments showed increased 17a-
hydroxylase (Cyp17a1) expression in these PCOS-theca cells [28],
confirming their pathological condition.
Figure 5. Cebpd-deficient females exhibit normal reproductive functions (A) Cebpd-deficient females generate normal-sized litters. Two to
three-month old females with wild-type Cebpd (WT, n=10) or Cebpd null mutation (KO, n=16) were mated, the male removed subsequent to
recording of a vaginal plug, and the number of pups of the following litter were counted within 24 hours after birth. (B) Cebpd-deficient females
display regular estrous cycles. Two month-old Cebpd null females (KO, n=5) and wild-type littermate controls (WT, n=4) were mated to
vasectomized, sterile males and monitored daily for the occurrence of vaginal plugs over a period of 40–50 days. The number of days between 19
plugs per group was averaged. (C) Cebpd-deficient females display normal progesterone levels. Progesterone levels were measured in serum from
mice on day 5 of gestation (from experiment in Fig. 5A, n=5 KO, 3 WT) or on day 5 of pseudopregnancy (from experiment in Fig. 5B, n=5 KO, 4 WT).
Means6S.E.M. are shown.
doi:10.1371/journal.pone.0001334.g005
Figure 6. Normal gene expression pattern in Cebpd-deficient ovaries. Phosphorimage quantification of Northern blot analyses for the indicated
genes of whole ovary total RNA from 5 week-old Cebpd null mice (KO) and litter mate controls (WT) treated for 2 days with PMSG followed by hCG for
4 hours. Expression levels were normalized to cyclophilin (Ppi) expression (a.u.=arbitrary units; means6SEM). Panel A: n=6 WT, 8 KO; Panel B: n=4
WT, 4 KO.
doi:10.1371/journal.pone.0001334.g006
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The CEBP family of transcription factors has many different
functions in a variety of physiological processes. In the ovary,
CEBPA and CEBPB play key roles in the LH response of the
follicle. Cebpa is widely and constitutively expressed in the rat
ovary. Cebpa expression levels do not change dramatically upon
hormone stimulation, and localize mostly to the granulosa cells
and theca cells of preovulatory follicles, with the highest levels in
cumulus cells. On the other hand Cebpb expression is rapidly and
highly induced by hCG mainly in granulosa cells. Knockdown and
targeted mutations have shown that both CEBPA and CEBPB are
important for ovulation and Cebpb-deficient mice are sterile
presumably due to a granulosa cell defect [8]. We used a
combination of expression studies and genetic analysis to assess the
function of CEBPD in the mouse ovary. We found that in contrast
to CEBPA and CEBPB, the CEBPD protein does not have a
critical or non-redundant role in the ovary. However, expression
of the Cebpd gene is acutely responsive to the LH surge in a select
group of interstitial cells within the ovarian stroma and in theca cells
of follicles. The diversity of cell type and hormone-response specific
expression of different Cebp genes demonstrates that this gene family
has been exploited in evolution to contribute to the development of
the ovary by providing unique functions for its variety of cell types.
Interestingly, expression of CEBPD in theca cells is not restricted to
pre-ovulatory follicles but was seen at all stages of follicular
development, beginning with primary follicles. In the stroma, we
observed that most alpha smooth muscle actin containing regions
harbor CEBPD-expressing cells, and were thus identified as early
responders to LH/hCG. To our knowledge, the only other
transcription factor gene previously reported as activated by LH/
hCG specifically in theca cells, is the zinc finger protein
gonadotropin-inducible transcription factor 1 (Giot1). However,
activation of Giot1 was detected only in theca interna cells and
was not observed in interstitial cells [29]. Remarkably, loss of
CEBPD did not have a detrimental effect on thecal cell function, as
might be expected, if it was essential for LH-induced steroidogenesis
(which is critical for follicular steroidogenesis) or thecal cell
development. However, it is possible that loss of CEBPD was
compensated byone of the otherCEBPs.For example, Cebpe mRNA
is detectable in whole ovary RNA, but its hormonal regulation or
cellular distribution has not yet been characterized [8].
A role for CEBPB in down regulation of Cebpd mRNA levels was
also observed after its initial activation by hCG. Cebpb is mainly
expressed in the inner follicular mass of granulosa cells. While we
cannot rule out a direct effect of low levels of CEBPB within
theca/interstitial cells as the primary mechanism for the observed
decline in Cebpd mRNA levels, it is tempting to speculate that
thecal Cebpd expression is regulated by juxtacrine/endocrine
factors from the granulosa cell compartment. A number of
cytokines, including several members of the EGF family, which are
induced in the granulosa layer by LH [27,30], are dramatically
downregulated in Cebpb null ovaries (L.K.C., E.S., unpublished
data) and, therefore, represent candidate feedback signals.
The observation that the Cebpd gene is not essential for fertility
in mice, does not rule out that the protein participates in ovarian
gene regulation. Therefore, misexpression or overactivity of
CEBPD could impact ovarian function in adverse ways. In
humans, hyperactivity of the theca/interstitial compartment is
associated with PCOS. In the present study, we evaluated Cebpd
levels in PCOS patient derived theca cells. Our results indicate
that Cebpd expression was elevated in theca cells that are producing
androgen and are in agreement with the chronically elevated
androgen levels and Cyp17a1 gene expression seen in PCOS theca
cells. However, our data are in contrast to an array-based
expression analysis of biopsies, which reports 2-fold lower levels of
Cebpd expression in PCOS tissue [31]. There are several potential
reasons for this discrepancy. The cultured cells used here were
derived from the theca layer of 5–6 mm follicles of both normal
and PCOS women, while the biopsies were random and therefore
of varying cell type composition that could be quite heterogeneous.
In contrast, the cultured theca cells from normal and PCOS
women would be more homogenous and comparable cell
populations, and cultured cells are known to maintain some of
their in vivo characteristics unique to PCOS such as elevated
Cyp17a1. However, the potential effect of culture conditions
affecting gene expression patterns can not be discounted either.
Because of the relatively small number of samples in this analysis
we primarily conclude that Cebpd expression in theca cells is not
specific to mice but also true for human cells. Our present results
lend support but far from confirm that CEBPD is possibly elevated
in thecal cells of PCOS women.
In summary, our data show that the Cebpd gene is rapidly
induced by LH/hCG in theca cells of primary follicles through
pre-ovulatory follicles as well as in interstitial cells. This
observation demonstrates some common characteristics in the
hormonal regulation between these cell populations. The data also
suggest that in contrast to CEBPA and CEBPB, CEBPD function
is not directly related to the ovulation process, but may rather have
a role in the broad endocrine activity of the theca/interstitial
compartment, or possibly the inflammatory response associated
with ovulation. The physiologic/developmental role of LH/hCG
responsive cells within the ovarian stroma compartment is
presently not understood. CEBPD can be a useful marker for
the early response of the theca/interstitial compartment to LH/
hCG and may help to further characterize these ovarian cell types.
MATERIALS AND METHODS
Mice
The generation of mice (Mus musculus) with targeted deletion of Cebpd
[19] and Cebpb [24] has been described previously. Wild-type and
mutant subjects were offspring from heterozygous breeding pairs.
Cebpb-deficient mice are not viable on a pure genetic background.
Thus,theexpressiondatainFigures1–3werederived frommiceofa
129B6-F1 strain background, generated by mating heterozygous
Figure 7. Cebpd is overexpressed in theca cells from PCOS patients.
Quantitative real-time RT-PCR results examining Cebpd mRNA expres-
sion in theca cells derived from four healthy women and four PCOS
patients are shown. Expression levels were normalized by Gapdh values
and the relative values are shown (a.u.=arbitrary units). The two-
sample independent t-test, for which the values were transformed to
their common logs, and the nonparametric Mann-Whitney test, both
yielded a statistically significant difference at P,0.03.
doi:10.1371/journal.pone.0001334.g007
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background, respectively. All other data were generated with mice
on a pure 129S1 strain background, which exhibit similar Cebpd
expression asthe 129B6-F1strain.Whereindicated,miceweregiven
intraperitoneal injections of pregnant mare serum gonadotropin
(PMSG, 5 IU, SIGMA; equivalent to equine chorionic gonado-
tropines, eCG) or human chorionic gonadotropin (hCG, 5 IU,
SIGMA).Themicewerehousedandbredinaspecificpathogen-free
facilitywitha12 hourlightcycle,andwithchowandwateradlibitum.
All procedures were conducted in compliance with the guidelines of
the Animal Care and Use Committee of the National Cancer
Institute, MD, U.S.A.
In situ analysis
Ovarieswere fixed in4%paraformaldehyde and 5 mm sectionswere
prepared from paraffin embedded tissues. In situ hybridization
analysis was performed as described [32], using a cRNA probe
representing the coding region for amino acids 1–181 of Cebpd.
Immunohistochemistry
Immunohistochemical staining was performed with the aid of an
automated immunostainer (DakoCytomation, Carpinteria, CA).
Formalin-fixed paraffin embedded tissue sections were mounted on
glass slides and deparaffinized. Prior to staining, heat-induced
antigen retrieval was performed by placing the slides into target
retrieval solution, high pH(DakoCytomation), and steaming them in
a commercial vegetable steamer at full temperature for 30 minutes
(CEBPD) or by pressure cooking in TRIS/Citrate (pH 6) for
8 minutes (alpha-smooth muscle actin, ACTA2). Following the
antigen retrieval procedure the slides were incubated with a CEBPD
rabbit polyclonal antibody (ActiveMotif cat#39006; dilution 1:500)
overnight at 4uC, or a monoclonal mouse antibody against ACTA2
(DAKO, Clone 1A4, dilution 1:500) for 1 hour. Detection was
carried out on the automated system using an HRP/DAB polymer
based rabbit detection system (Envision+, DakoCytomation) accord-
ing to the manufacturer’s recommendations.
Progesterone assay
Serum was prepared from orbital eye bleeds and progesterone levels
were assessed with the DSL-10-3900 ACTIVE progesterone EIA kit
(Diagnostic Systems Laboratories, Inc.), according to the manufac-
turer’s instructions. Each sample was assayed in duplicate. The
coefficient of variation across experiments and genotypes was 0.35.
RNA analysis
Total ovarian RNA was prepared by homogenization of tissue in
Trizol reagent (Life Technologies, Inc.) according to the manufac-
turer’s protocol. The RNA was analyzed by Northern blotting as
described [33] except that hybridizations were carried out in
HybPlus solution (SigmaAldrich, Inc.). Radiolabeled DNA probes
were prepared from isolated mouse cDNA clones for the indicated
genes. The specific signals were recorded and quantified by
phosphorimage analysis (Molecular Dynamics, ImageQuant
TM).
Human theca cell culture and real time PCR analysis
Human theca interna tissue was obtained from follicles of women
undergoing hysterectomy, following informed consent under a
protocol approved by the Institutional Review Board of the
Pennsylvania State University College of Medicine. In the
experiments presented in this manuscript, 3
rd and 4
th passage
(31–38 population doublings) theca cells isolated from size-
matched follicles obtained from age-matched subjects were used
as previously described [34,35]. All of the PCOS theca
preparations studied came from ovaries of women with fewer
than six menstrual periods per year and elevated serum total
testosterone (T) or bioavailable T levels, as we previously described
(26). The control (normal) theca cell preparations came from
ovaries of fertile women with normal menstrual histories,
menstrual cycles of 21–35 d, and no signs of hyperandrogenemia.
The OB/Gyn department at Penn State Medical Center routinely
schedules hysterectomies of reproductive aged women during their
follicular phase.
Total RNA (5 mg) isolated with Trizol reagent (Life Technol-
ogies, Inc.) was treated with DNase I (Promega, Madison, WI)
followed by cDNA synthesis using the MMLV reverse transcrip-
tase (Promega) and oligo dT primer (Promega) as previously
described [35]. The resulting cDNAs were diluted 1:100 in sterile
water and 1-ml aliquots were used in the quantitative real-time
PCRs reactions. The primers used to quantify Cebpd (Forward: 59-
GGTGCCCGCTGCAGTTT-39; Reverse: 59-CTCGCAGTT-
TAGTGGTGGTAAGTC-39) were designed with Primer Express
software package that accompanies the Applied Biosystems Model
7900 sequence detector (PerkinElmer Life Science). The SyBr
green reagent PCR Master Mix (Applied Biosystems) was used as
previously described [36]. In order to account for differences in
starting material, the human glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) primers and probe reagents from Applied
Biosystems were used as described by the manufacturer. In order
to quantify differences, the samples were compared to standard
curves for each target amplicon and the average value for the
triplicate was used in all subsequent calculations.
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